MA51311A - Vaccins contre le virus de l'hépatite b (vhb) et utilisations associées - Google Patents
Vaccins contre le virus de l'hépatite b (vhb) et utilisations associéesInfo
- Publication number
- MA51311A MA51311A MA051311A MA51311A MA51311A MA 51311 A MA51311 A MA 51311A MA 051311 A MA051311 A MA 051311A MA 51311 A MA51311 A MA 51311A MA 51311 A MA51311 A MA 51311A
- Authority
- MA
- Morocco
- Prior art keywords
- hbv
- vaccines
- hepatitis
- virus
- related uses
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762607426P | 2017-12-19 | 2017-12-19 | |
IB2017058142 | 2017-12-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA51311A true MA51311A (fr) | 2020-10-28 |
Family
ID=65199441
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA051311A MA51311A (fr) | 2017-12-19 | 2018-12-18 | Vaccins contre le virus de l'hépatite b (vhb) et utilisations associées |
Country Status (15)
Country | Link |
---|---|
EP (2) | EP4272833A3 (fr) |
JP (1) | JP7317017B2 (fr) |
KR (1) | KR20200101416A (fr) |
CN (1) | CN111836641A (fr) |
AU (1) | AU2018389787A1 (fr) |
BR (1) | BR112020011976A2 (fr) |
CA (1) | CA3086327A1 (fr) |
ES (1) | ES2963179T3 (fr) |
IL (1) | IL275427B2 (fr) |
JO (1) | JOP20200153A1 (fr) |
MA (1) | MA51311A (fr) |
MX (3) | MX2020006480A (fr) |
PH (1) | PH12020550924A1 (fr) |
SG (1) | SG11202005895QA (fr) |
WO (1) | WO2019123252A1 (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110073002B (zh) | 2016-10-17 | 2024-06-11 | 杨森制药公司 | 重组病毒复制子体系及其用途 |
KR102655641B1 (ko) | 2016-12-05 | 2024-04-05 | 얀센 파마슈티칼즈, 인코포레이티드 | 유전자 발현을 향상시키기 위한 조성물 및 방법 |
EA202091517A1 (ru) | 2017-12-19 | 2020-11-03 | Янссен Сайенсиз Айрлэнд Анлимитед Компани | Способы и устройство для доставки вакцин против вируса гепатита b (hbv) |
EA202091513A1 (ru) | 2017-12-19 | 2020-09-09 | Янссен Сайенсиз Айрлэнд Анлимитед Компани | Вакцины против вируса гепатита b (hbv) и их применение |
EP3740245A4 (fr) | 2018-01-19 | 2022-01-05 | Janssen Pharmaceuticals, Inc. | Induction et amélioration des réponses immunitaires à l'aide de systèmes de réplicon de recombinaison |
WO2020255018A1 (fr) * | 2019-06-18 | 2020-12-24 | Janssen Sciences Ireland Unlimited Company | Vaccins contre le virus de l'hépatite b (vhb) et utilisations associées |
US20220313815A1 (en) * | 2019-06-20 | 2022-10-06 | Janssen Sciences Ireland Unlimited Company | Self-replicating rna molecules for hepatitis b virus (hbv) vaccines and uses thereof |
WO2022133230A1 (fr) * | 2020-12-18 | 2022-06-23 | Janssen Pharmaceuticals, Inc. | Polythérapie pour le traitement d'une infection par le virus de l'hépatite b |
AU2022311974A1 (en) * | 2021-07-16 | 2024-02-22 | Mcmaster University | Viral vaccine |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3883899T3 (de) | 1987-03-18 | 1999-04-22 | Sb2, Inc., Danville, Calif. | Geänderte antikörper. |
US5273525A (en) | 1992-08-13 | 1993-12-28 | Btx Inc. | Injection and electroporation apparatus for drug and gene delivery |
CA2168583C (fr) * | 1993-08-02 | 2007-10-02 | Francis V. Chisari | Peptides induisant des reactions cytotoxiques des lymphocytes t contre le virus de l'hepatite b |
US6041252A (en) | 1995-06-07 | 2000-03-21 | Ichor Medical Systems Inc. | Drug delivery system and method |
US6261281B1 (en) | 1997-04-03 | 2001-07-17 | Electrofect As | Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells |
EA002087B1 (ru) | 1997-04-03 | 2001-12-24 | Электрофект Ас | Способ введения фармацевтических препаратов и нуклеиновых кислот в скелетную мышцу |
US5873849A (en) | 1997-04-24 | 1999-02-23 | Ichor Medical Systems, Inc. | Electrodes and electrode arrays for generating electroporation inducing electrical fields |
US6117660A (en) | 1997-06-10 | 2000-09-12 | Cytopulse Sciences, Inc. | Method and apparatus for treating materials with electrical fields having varying orientations |
WO1999001158A1 (fr) | 1997-06-30 | 1999-01-14 | Rhone-Poulenc Rorer S.A. | Amelioration du transfert d'acide nucleique dans le muscle strie et combinaison permettant la mise en oeuvre du procede |
AU770092B2 (en) | 1998-07-13 | 2004-02-12 | Genetronics, Inc. | Skin and muscle-targeted gene therapy by pulsed electrical field |
US6319901B1 (en) | 1998-10-15 | 2001-11-20 | Ichor Medical Systems, Inc. | Methods for prolonging cell membrane permeability |
KR20030074787A (ko) * | 2001-02-05 | 2003-09-19 | 스트레스젠 바이오테크놀러지스 코포레이션 | B형 간염 바이러스 치료 |
US7245963B2 (en) | 2002-03-07 | 2007-07-17 | Advisys, Inc. | Electrode assembly for constant-current electroporation and use |
US8209006B2 (en) | 2002-03-07 | 2012-06-26 | Vgx Pharmaceuticals, Inc. | Constant current electroporation device and methods of use |
US6912417B1 (en) | 2002-04-05 | 2005-06-28 | Ichor Medical Systmes, Inc. | Method and apparatus for delivery of therapeutic agents |
US7328064B2 (en) | 2002-07-04 | 2008-02-05 | Inovio As | Electroporation device and injection apparatus |
US9364664B2 (en) | 2004-03-08 | 2016-06-14 | Ichor Medical Systems, Inc. | Apparatus for electrically mediated delivery of therapeutic agents |
CN105457157B (zh) | 2006-10-17 | 2020-04-14 | 因诺维奥制药公司 | 电穿孔装置及用其进行哺乳动物细胞电穿孔的方法 |
KR100836745B1 (ko) * | 2007-01-31 | 2008-06-10 | (주)두비엘 | Hbv 백신 및 그의 제조 방법 |
US8877205B2 (en) * | 2011-02-12 | 2014-11-04 | Globeimmune, Inc. | Yeast-based therapeutic for chronic hepatitis B infection |
TWI575070B (zh) * | 2011-07-12 | 2017-03-21 | 傳斯堅公司 | Hbv聚合酶突變體 |
CA3018223A1 (fr) | 2016-03-28 | 2017-10-05 | Ichor Medical Systems, Inc. | Procede et appareil permettant d'administrer des agents therapeutiques |
CN118063563A (zh) * | 2016-04-06 | 2024-05-24 | 华盛顿大学 | 用于乙型肝炎病毒(hbv)的使用hbv核心抗原的治疗性疫苗 |
-
2018
- 2018-12-18 AU AU2018389787A patent/AU2018389787A1/en active Pending
- 2018-12-18 JP JP2020533746A patent/JP7317017B2/ja active Active
- 2018-12-18 JO JOP/2020/0153A patent/JOP20200153A1/ar unknown
- 2018-12-18 CA CA3086327A patent/CA3086327A1/fr active Pending
- 2018-12-18 MA MA051311A patent/MA51311A/fr unknown
- 2018-12-18 KR KR1020207020752A patent/KR20200101416A/ko not_active Application Discontinuation
- 2018-12-18 CN CN201880089615.2A patent/CN111836641A/zh active Pending
- 2018-12-18 ES ES18839543T patent/ES2963179T3/es active Active
- 2018-12-18 WO PCT/IB2018/060259 patent/WO2019123252A1/fr unknown
- 2018-12-18 IL IL275427A patent/IL275427B2/en unknown
- 2018-12-18 BR BR112020011976-8A patent/BR112020011976A2/pt unknown
- 2018-12-18 EP EP23191303.9A patent/EP4272833A3/fr active Pending
- 2018-12-18 EP EP18839543.8A patent/EP3727445B1/fr active Active
- 2018-12-18 MX MX2020006480A patent/MX2020006480A/es unknown
- 2018-12-18 SG SG11202005895QA patent/SG11202005895QA/en unknown
-
2020
- 2020-06-16 PH PH12020550924A patent/PH12020550924A1/en unknown
- 2020-07-13 MX MX2020011802A patent/MX2020011802A/es unknown
- 2020-07-13 MX MX2020011804A patent/MX2020011804A/es unknown
Also Published As
Publication number | Publication date |
---|---|
SG11202005895QA (en) | 2020-07-29 |
JP7317017B2 (ja) | 2023-07-28 |
WO2019123252A1 (fr) | 2019-06-27 |
KR20200101416A (ko) | 2020-08-27 |
AU2018389787A1 (en) | 2020-06-25 |
EP4272833A2 (fr) | 2023-11-08 |
IL275427A (en) | 2020-08-31 |
PH12020550924A1 (en) | 2021-05-31 |
BR112020011976A2 (pt) | 2020-11-24 |
ES2963179T3 (es) | 2024-03-25 |
IL275427B1 (en) | 2023-12-01 |
EP3727445B1 (fr) | 2023-08-16 |
EP4272833A3 (fr) | 2024-01-10 |
EP3727445C0 (fr) | 2023-08-16 |
CA3086327A1 (fr) | 2019-06-27 |
JP2021509107A (ja) | 2021-03-18 |
MX2020011802A (es) | 2020-12-07 |
JOP20200153A1 (ar) | 2022-10-30 |
EP3727445A1 (fr) | 2020-10-28 |
MX2020006480A (es) | 2020-09-22 |
CN111836641A (zh) | 2020-10-27 |
MX2020011804A (es) | 2020-12-07 |
IL275427B2 (en) | 2024-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA51311A (fr) | Vaccins contre le virus de l'hépatite b (vhb) et utilisations associées | |
MA50813A (fr) | Vaccins contre le virus d'epstein-barr | |
MA49463A (fr) | Vaccin contre le virus de l'herpès simplex | |
HK1248681A1 (zh) | 作為hbsag(hbv表面抗原)和hbv dna生成的抑制劑用於治療乙型肝炎病毒感染的四氫吡啶並嘧啶和四氫吡啶並吡啶類化合物 | |
HK1255502A1 (zh) | B型肝炎病毒(hbv)irna組合物及其使用方法 | |
MA50520A (fr) | Nouveaux indole-2-carboxamides à substitution pyrazolo-pipéridine hautement actifs agissant contre le virus de l'hépatite b (vhb) | |
EP3710049A4 (fr) | Vaccin thérapeutique contre le virus de l'hépatite b (vhb) utilisant les régions pres1 et/ou pres2 et/ou s-hbsag du vhb de la protéine d'enveloppe du vhb | |
MA50524A (fr) | Nouveaux indole-2-carboxamides à substitution amino-thiazole hautement actifs agissant contre le virus de l'hépatite b (vhb) | |
MA51292A (fr) | Méthodes et appareil pour l'administration de vaccins contre le virus de l'hépatite b (vhb) | |
EP3439696A4 (fr) | Vaccin thérapeutique contre le virus de l'hépatite b (vhb) utilisant l'antigène nucléocapsidique du vhb | |
MA51312A (fr) | Méthodes et compositions permettant d'induire une réponse immunitaire contre le virus de l'hépatite b (vhb) | |
HK1251010A1 (zh) | 用於治療乙型肝炎病毒(hbv)感染的試劑及用途 | |
IL273093A (en) | Combination of drugs for the treatment of hepatitis B virus type HBV patients using Parafoxvirus Obis (PPVO) and at least one other antiviral agent | |
MA56535A (fr) | Molécules d'arn à auto-réplication pour vaccins contre le virus de l'hépatite b (vhb) et utilisations associées | |
SG11201808266QA (en) | Hepatitis b treatment vaccine on the basis of inactivated, fully recombinant hansenula cells expressing hbsag | |
MA56524A (fr) | Vecteurs d'arénavirus pour vaccins contre le virus de l'hépatite b (vhb) et utilisations associées | |
MA45994A (fr) | Vaccins contre des virus | |
IL277128A (en) | Hepatitis B vaccines and their uses | |
MA56533A (fr) | Combinaison de vaccins contre le virus de l'hépatite b (vhb) et d'anticorps anti-pd-1 | |
ZA202104076B (en) | Hepatitis b virus vaccine and uses thereof | |
WO2014160088A3 (fr) | Traitement d'infections par le virus de l'hépatite b | |
EP3452595A4 (fr) | Réactifs pour le traitement d'infection par le virus de l'hépatite b (vhb) et utilisation de ceux-ci | |
IL286484B (en) | Reagents for treatment of hepatitis b virus (hbv) infection and use thereof | |
GB201702193D0 (en) | Hepatitis E virus vaccine | |
PL3244921T3 (pl) | Immunogenna szczepionka przeciwko wirusowi HCV i/lub HBV |